⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Precision Oncology Approaches Drive $312B Market Transformation
prnewswire.com
GTBP
NRIX
GRAL
CCCC
PFE
GTBP
NRIX
GRAL
CCCC
PFE
ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain
businesswire.com
PFE
ViiV Healthcare’s CLARITY study shows long-acting cabotegravir more acceptable than lenacapavir injections after a single dose, with 90% preferring cabotegravir
businesswire.com
PFE
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial
businesswire.com
PFE
Pfizer Declares Fourth-Quarter 2025 Dividend
businesswire.com
PFE
Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025
prnewswire.com
PFE
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
businesswire.com
PFE
Hearing Against Pfizer Set For 29 September In Contraceptive ‘Depo-Provera’ Multidistrict Litigation Overseen By Levin Papantonio
businesswire.com
PFE
PFE
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
businesswire.com
PFE
METSERA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Metsera, Inc. - MTSR
businesswire.com
MTSR
PFE